There are ongoing attempts to target BCAT1 for the treatment of glioblastoma.62 These observations suggest that stratification of tumors by BCAT1 expression may be necessary in order to select patients that could potentially respond to such therapeutic intervention. The gene discussed is BCAT1; the disease is glioblastoma.